These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 8083518)

  • 41. Reduction of the accumulation of viral mRNA and of cellular rRNA synthesis in MHV3-infected macrophages of resistant mice.
    Lucchiari MA; Martin JP; Modolell M; Pereira CA
    Braz J Med Biol Res; 1994 Mar; 27(3):601-11. PubMed ID: 8081284
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Macrophages and viral immunity.
    Silverstein S
    Semin Hematol; 1970 Apr; 7(2):185-214. PubMed ID: 4317324
    [No Abstract]   [Full Text] [Related]  

  • 43. Rapid killing of actinomycin D-treated tumor cells by human mononuclear cells. I. Effectors belong to the monocyte-macrophage lineage.
    Colotta F; Peri G; Villa A; Mantovani A
    J Immunol; 1984 Feb; 132(2):936-44. PubMed ID: 6690624
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A 2',5'-oligoadenylate analogue inhibits murine hepatitis virus strain 3 (MHV-3) replication in vitro but does not reduce MHV-3-related mortality or induction of procoagulant activity in susceptible mice.
    Fingerote RJ; Cruz BM; Gorczynski RM; Fung LS; Hubbell HR; Suhadolnik RJ; Levy GA
    J Gen Virol; 1995 Feb; 76 ( Pt 2)():373-80. PubMed ID: 7844557
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Generation of antiviral CD11ahigh T cells in CD4+ T cell-depleted mice and adult thymectomized mice after mouse hepatitis virus infection.
    Kyuwa S; Machii K; Okumura A
    J Vet Med Sci; 1996 May; 58(5):465-7. PubMed ID: 8741611
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The potential use of liposome-mediated antiviral therapy.
    Koff WC; Fidler IJ
    Antiviral Res; 1985 Jun; 5(3):179-90. PubMed ID: 3896138
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Role of CD4-CD8- T cells in the murine hepatitis virus type 3 induced chronic viral hepatitis].
    Wang XJ; Yan WM; Zhang JG; Wang HW; Zou Y; Luo XP; Ning Q
    Zhonghua Gan Zang Bing Za Zhi; 2009 Mar; 17(3):180-3. PubMed ID: 19335979
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Loss of resistance to murine hepatitis virus strain 3 infection after treatment with corticosteroids is associated with induction of macrophage procoagulant activity.
    Fingerote RJ; Abecassis M; Phillips MJ; Rao YS; Cole EH; Leibowitz J; Levy GA
    J Virol; 1996 Jul; 70(7):4275-82. PubMed ID: 8676449
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Gene expression in IFN-gamma-activated murine macrophages.
    Pereira CA; Modolell M; Frey JR; Lefkovits I
    Braz J Med Biol Res; 2004 Dec; 37(12):1795-809. PubMed ID: 15558186
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Interaction of herpes simplex virus with mononuclear phagocytes is dependent on the differentiation stage of the cells.
    Bruun T; Kristoffersen AK; Rollag H; Degré M
    APMIS; 1998 Feb; 106(2):305-14. PubMed ID: 9531964
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Toll-like receptor-2 exacerbates murine acute viral hepatitis.
    Bleau C; Burnette M; Filliol A; Piquet-Pellorce C; Samson M; Lamontagne L
    Immunology; 2016 Oct; 149(2):204-24. PubMed ID: 27273587
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparison of antiviral and antitumor activity of activated macrophages.
    Morahan PS; Glasgow LA; Crane JL; Kern ER
    Cell Immunol; 1977 Feb; 28(2):404-15. PubMed ID: 191199
    [No Abstract]   [Full Text] [Related]  

  • 53. Control of mouse hepatitis virus replication in macrophages by a recessive gene on chromosome 7.
    Smith MS; Click RE; Plagemann PG
    J Immunol; 1984 Jul; 133(1):428-32. PubMed ID: 6327825
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pathogenesis of enterotropic mouse hepatitis virus in immunocompetent and immunodeficient mice.
    Compton SR; Ball-Goodrich LJ; Johnson LK; Johnson EA; Paturzo FX; Macy JD
    Comp Med; 2004 Dec; 54(6):681-9. PubMed ID: 15679267
    [TBL] [Abstract][Full Text] [Related]  

  • 55. TNF-alpha-converting enzyme cleaves the macrophage colony-stimulating factor receptor in macrophages undergoing activation.
    Rovida E; Paccagnini A; Del Rosso M; Peschon J; Dello Sbarba P
    J Immunol; 2001 Feb; 166(3):1583-9. PubMed ID: 11160199
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mouse mononuclear cell chemotaxis. I. Differential response of monocytes and macrophages.
    Boumsell L; Meltzer MS
    J Immunol; 1975 Dec; 115(6):1746-8. PubMed ID: 1184970
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Severe combined immunodeficiency (SCID) mouse hepatitis experimentally induced with low virulence mouse hepatitis virus.
    Uetsuka K; Nakayama H; Goto N; Fujiwara K
    Adv Exp Med Biol; 1995; 380():105-7. PubMed ID: 8830462
    [No Abstract]   [Full Text] [Related]  

  • 58. Proceedings: Cell-mediated defence against virus infections in mice.
    Plantinga AD; de Jong JC; Harmsen M; Straaten-Hekerman MP; Khader Boutahar-Trouw BJ
    Antonie Van Leeuwenhoek; 1975; 41(2):216. PubMed ID: 1080401
    [No Abstract]   [Full Text] [Related]  

  • 59. Replication of murine cytomegalovirus in differentiated macrophages as a determinant of viral pathogenesis.
    Hanson LK; Slater JS; Karabekian Z; Virgin HW; Biron CA; Ruzek MC; van Rooijen N; Ciavarra RP; Stenberg RM; Campbell AE
    J Virol; 1999 Jul; 73(7):5970-80. PubMed ID: 10364349
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mouse hepatitis virus spike and nucleocapsid proteins expressed by adenovirus vectors protect mice against a lethal infection.
    Wesseling JG; Godeke GJ; Schijns VE; Prevec L; Graham FL; Horzinek MC; Rottier PJ
    J Gen Virol; 1993 Oct; 74 ( Pt 10)():2061-9. PubMed ID: 8409930
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.